Azithromycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70860-100

2 FDA label images from Athenex Pharmaceutical Division, Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 70860-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Athenex Pharmaceutical Division, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Azi02 0009 01)

Structural Formula (Azi02 0009 01)
Chemical structure of azithromycin monohydrate, showing the detailed molecular arrangement of this macrolide antibiotic.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Azi02 0009 02)

Package Label – Principal Display Panel – Vial Label (Azi02 0009 02)
Label for Azithromycin for Injection, USP 500 mg per vial, equivalent to azithromycin, powder for injection intended for intravenous infusion. Single-dose vial, sterile, preservative-free, and nonpyrogenic. Manufactured by Athenex Pharmaceutical Division, LLC, Schaumburg, IL, made in India. Label includes barcode, lot, and expiration area notes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.